Multicenter, Randomised, Double Blind Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

Trial Profile

Multicenter, Randomised, Double Blind Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

Discontinued
Phase of Trial: Phase III

Latest Information Update: 06 Nov 2015

At a glance

  • Drugs Losartan (Primary)
  • Indications Marfan's syndrome
  • Focus Therapeutic Use
  • Acronyms MARFAN-SARTAN; MARFANSARTAN
  • Most Recent Events

    • 13 Jun 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 10 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top